The Brazilian regulatory agency ANVISA temporarily suspended activity at a contract manufacturer for Sientra Inc. (Nasdaq: SIEN) sending the stock price plummeting $2.19 to close at $8.18.
The Dow Chemical Company (NYSE: DOW) closed the transaction to separate its chlor-alkali and downstream derivatives business. The stock price climbed $1.86 to close at $46.31.
Shares of California Resources Corp. (NYSE: CRC) climbed 59 cents to close at $3.60 and Energy XXI Ltd. (Nasdaq: EXXI) gained 26 cents to close at $1.45 as crude oil prices rose.
Citron tweeted that Valeant Pharmaceuticals International Inc. (NYSE: VRX) was a lemon. The stock price plummeted $19.28 to $163.04.
Spark Therapeutics Inc. (Nasdaq: ONCE) reported upbeat data from a Phase 3 trial of SPK-RPE65 sending the stock price soaring $9.23 to $53.16.
ContraVir Pharmaceuticals Inc. (Nasdaq: CTRV) reported preliminary positive data for its CMX157 to treat hepatitis B sending shares of the biopharmaceutical soaring $2.01 to $4.12.
Bargain hunters lifted shares of Esperion Therapeutics Inc. (Nasdaq: ESPR) $5.26 to close at $23.59.
Institutional Shareholder Services recommended that DepoMed Inc. (Nasdaq: DEPO) hold a special shareholder meeting to consider Horizon Pharma's (Nasdaq: HZNP) acquisition offer. Shares of DepoMed leaped $3.35 to close at $18.85 while Horizon Pharma stock surged $3.01 to close at $19.82.
C&J Energy Services Ltd. (NYSE: CJES) amended its credit facilities and warned that third quarter results will fall short of expectations sending the stock price down 74 cents to close at $3.52.
Bloomberg reported that Synaptics Inc. (Nasdaq: SYNA) rejected on acquisition offer from a Chinese investor that valued the company at approximately $4 billion. The stock price leaped $14.91 to $79.68.